Tarveda Therapeutics   Report issue

For profit Phase 2
Founded: Watertown MA United States (2012)

Organization Overview

First Clinical Trial
2016
NCT02936323
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Tarveda Therapeutics